SHANGHAI – While perusing the list of China’s most promising biopharmaceutical companies, a surprising fact emerges: Many are not registered in China as purely domestic firms, but operate here as wholly foreign-owned enterprises under a Cayman Islands holding company. Cayman Islands is a well-known business-friendly tax haven.